EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Improving immune‐related health outcomes post‐cesarean birth with a gut microbiome‐based program: A randomized controlled trial

Pamela A Nieto iD, Claudia Nakama, Julian Trachsel iD, David Goad, Taylor K Soderborg, Danielle Shea Tan, Amy Orlandi, Qian Yuan iD, Elisa Song, Noel T Mueller, Ruben A Mars, Cheryl Sew Hoy und 1 weitere

Pediatric Allergy and Immunology · 2025-09 · 36 (9)

DOI: 10.1111/pai.70182 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 02.09.2025. Verfasst von Pamela A Nieto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Seeding Inc, Doing Business as Tiny Health, Austin, Texas, USA. Hauptthemen laut MEDLINE: Cesarean Section, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Seeding Inc. DBA Tiny Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infants born via Cesarean section (C‐section) often have a distinct gut microbiome and higher risks of atopic and immune‐related conditions than vaginally delivered infants. We evaluated whether a microbiome‐based program could shift gut microbiome composition and improve microbiome‐associated health outcomes in C‐section born infants.

Methods

This open‐label, randomized, controlled trial included full‐term C‐section‐born infants aged 0–3 months, randomized to an intervention ( n = 25) or control arm ( n = 29). Over 6 months, the intervention arm received two microbiome reports, personalized recommendations based on their microbiome, educational materials, and coaching calls focused on microbiome health. Parents reported health conditions via surveys. Primary outcome: Difference between study arms in relative abundance of key gut microbiome taxa and functional genes. Other outcomes: Changes in a C‐section index—a taxonomy‐based metric comparing C‐section‐associated taxa to vaginally‐associated taxa—and prevalence of atopic conditions.

Results

Compared to controls, the intervention arm had higher Bifidobacterium ( p = .025, q = .121) and higher abundance of genes associated with human milk oligosaccharide degradation (e.g., α‐L‐fucosidase, p = .019, q = .046) at timepoint 2. In the intervention arm, the C‐section index decreased to a level similar to vaginally born infants ( p = .807, q = .807). At the end of the intervention, atopic dermatitis prevalence was lower in the intervention arm than in controls (odds ratio, 0.17 [95% CI, 0.023–0.723], p = .031).

Conclusion

A personalized microbiome‐based program can modulate the gut microbiome of C‐section‐born infants and may reduce the risk of atopic conditions ( ClinicalTrials.gov : NCT06424691).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cesarean SectionGastrointestinal MicrobiomeFemaleHumansInfantInfant, NewbornMalePregnancy

Stichwörter der Autor:innen

atopic dermatitisbifidobacteriumcesarean sectiongutinfant gutmicrobiome

Autor:innen und Institutionen

  • Seeding Inc, Doing Business as Tiny Health, Austin, Texas, USA.
  • Food Allergy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Whole Family Wellness, Belmont, California, USA.
  • Healthy Kids Happy Kids, Belmont, California, USA.
  • Department of Pediatrics, Section of Nutrition, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Epidemiology, Colorado School of Public Health, Denver, Colorado, USA.

ORCID-Profile: Pamela A Nieto, Julian Trachsel, Qian Yuan

Förderung

  • Seeding Inc. DBA Tiny Health

Zitieren

APA

Nieto, P. A., Nakama, C., Trachsel, J., Goad, D., Soderborg, T. K., Tan, D. S., Orlandi, A., Yuan, Q., Song, E., Mueller, N. T., Mars, R. A., Hoy, C. S., & Sukhum, K. V. (2025). Improving immune‐related health outcomes post‐cesarean birth with a gut microbiome‐based program: A randomized controlled trial. Pediatric Allergy and Immunology, 36(9). https://doi.org/10.1111/pai.70182

Vancouver

Nieto PA, Nakama C, Trachsel J, Goad D, Soderborg TK, Tan DS, et al. Improving immune‐related health outcomes post‐cesarean birth with a gut microbiome‐based program: A randomized controlled trial. Pediatric Allergy and Immunology. 2025;36(9). doi:10.1111/pai.70182

BibTeX
@article{Nieto2025,
  author = {Nieto, Pamela A and Nakama, Claudia and Trachsel, Julian and Goad, David and Soderborg, Taylor K and Tan, Danielle Shea and Orlandi, Amy and Yuan, Qian and Song, Elisa and Mueller, Noel T and Mars, Ruben A and Hoy, Cheryl Sew and Sukhum, Kimberley V},
  title = {Improving immune‐related health outcomes post‐cesarean birth with a gut microbiome‐based program: A randomized controlled trial},
  journal = {Pediatric Allergy and Immunology},
  year = {2025},
  volume = {36},
  number = {9},
  doi = {10.1111/pai.70182}
}
Kostenlos starten →